LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Mason, MD
University of Alberta, Edmonton
Principal Investigator - Barry G Rosser, MD
Mayo Clinic
Principal Investigator - Elizabeth Carey, MD
Mayo Clinic
Principal Investigator - Gerald Y Minuk, M.D.
University of Manitoba Health Sciences Centre, Winnipeg
Principal Investigator - John R Lake, MD
University of Minnesota
Principal Investigator - Joseph A Odin, MD, PhD
Mount Sinai Medical Center, New York, NY
Principal Investigator - Kevork M Peltekian, MD
Queen Elizabeth II Health Sciences Centre
Principal Investigator - Mark G Swain, MD
University of Calgary
Principal Investigator - Velimir A Luketic, MD
Virginia Commonwealth University, Richmond, VA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heritage Medical Research Clinic
Calgary, Alberta, Canada
- Zeildler Ledcor Centre
Edmonton, Alberta, Canada
- John Buhler Research Centre, University of Manitoba Health Sciences Centre
Winnipeg, Manitoba, Canada
- Queen Elizabeth Ii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Mayo Clinic - Phoenix
Phoenix, Arizona, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Mount Sinai Medical Center
New York, New York, United States
- St. Luke'S Advanced Liver Therapies
Houston, Texas, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 30 Apr 2009
- Completion
- 31 Jul 2009
- Last update posted
- 17 Mar 2020
- Registered enrollment
- 13
- Registry id
- NCT00608894
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.